Medicamentos genéricos: oriente-se

Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária - ANVISA.
Brasília; Ministério da Saúde; 2002. 31 p. ilus.
Monografia em Português | Coleciona SUS | ID: biblio-920356

Documentos relacionados

  1. Generic Drugs Not as Safe as FDA Wants You to Believe.
  2. Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages.
  3. A new paradigm for topical generic drug products: Impact on therapeutic access.
  4. Diving into Batch-to-Batch Variability of Topical Products-a Regulatory Bottleneck.
  5. Cancer drug shortages: Awareness and perspectives from a representative sample of the US population.
  6. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities.
  7. Global access to affordable direct oral anticoagulants.
  8. Are we underdosing acne patients with generic isotretinoin?
  9. Drugs are going missing, but why?
  10. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.